Archive

2022-07-07
NeoDynamics receives ethical approval for German device registry
Read more

2022-06-17
Gryningskust Holding AB increases ownership in NeoDynamics
Read more

2022-06-09
Update on the FDA approval process for NeoNavia®
Read more

2022-05-24 Regulatory
Communiqué from the annual general meeting in NeoDynamics AB (publ)
Read more

2022-05-18
NeoDynamics Newsletter, May 2022
Read more

2022-05-17 Regulatory
New data from NeoDynamics’ PULSE study presented at major US breast imaging conference
Read more

2022-05-12 Regulatory
NeoDynamics AB (publ) first quarter 2022
Read more

2022-05-02
Trading in NeoDynamics shares on Nasdaq First North starts today
Read more

2022-04-28 Regulatory
NeoDynamics publishes supplementary document introducing listing on Nasdaq First North Growth Market
Read more

2022-04-27 Regulatory
NeoDynamics publishes Annual Report 2021
Read more

2022-04-26 Regulatory
Last day of trading in paid subscription shares (Sw.BTA)
Read more

2022-04-13 Regulatory
NeoDynamics conditionally approved for listing on Nasdaq First North
Read more

2022-03-28 Regulatory
NeoDynamics announces outcome of rights issue
Read more

2022-03-15
NeoDynamics sets up NeoDynamics USA Inc.
Read more

2022-03-01
NeoDynamics has filed for registration of NeoNavia® in the US
Read more

2022-02-25 Regulatory
Communique from extraordinary general meeting in NeoDynamics AB (publ)
Read more

2022-02-16
NeoDynamics to present Q4 report on Feb 21 at 12.30
Read more

2022-02-16 Regulatory
NeoDynamics AB (publ) full-year report 2021
Read more

2022-02-09 Regulatory
Notice of extraordinary general meeting in NeoDynamics AB
Read more

2022-01-24
Interview and company presentation in collaboration with Uddaaktier
Read more

2022-01-20
New data from NeoDynamics PULSE study accepted for presentation at major US breast imaging conference
Read more

2022-01-17
NeoDynamics to present at Redeye Fight Cancer Seminar 20 Jan 2022
Read more

2021-11-24
NeoDynamics appoints Aaron Wong as CFO
Read more

2021-11-17 Regulatory
Interim report Q3 2021
Read more

2021-11-15
NeoDynamics presents Q3 report
Read more

2021-11-08
NeoDynamics presents first results from PULSE study
Read more

2021-10-28
NeoDynamics starts subsidiary in Germany
Read more

2021-09-17
NeoDynamics confirms four orders for NeoNavia
Read more

2021-09-13
NeoDynamics demonstrates NeoNavia live at congresses
Read more

2021-08-25 Regulatory
NeoDynamics granted a U.S. patent for its biopsy needle
Read more

2021-08-19 Regulatory
Interim report Jan-June 2021
Read more

2021-07-09
NeoDynamics receives first German order of pulse biopsy system NeoNavia
Read more

2021-05-31
NeoDynamics presents at Redeye Growth Day 2021
Read more

2021-05-19 Regulatory
First quarter - Introduction underway
Read more

2021-05-17
NeoDynamics presents an abstract on pulse biopsy data for NeoNavia at the UK Association of Breast Surgeons Conference 2021
Read more

2021-04-27
Matthew E. Colpoys, Jr. nominated to the Board of Directors
Read more

2021-03-17
NeoDynamics presents preclinical results today
Read more

2021-03-15
Invitation - NeoDynamics presents preclinical results on March 17 at 13.00 CET
Read more

2021-02-17 Regulatory
NeoDynamics AB (publ) Full year report 2020
Read more

2021-01-14
NeoDynamics will be granted another European patent for its pulse biopsy tools
Read more

2020-11-19 Regulatory
NeoDynamics AB (publ) Third Quarter 2020
Read more

2020-11-19 Regulatory
NeoDynamics receives first UK order of pulse biopsy system NeoNavia
Read more

2020-11-12
NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis
Read more

2020-11-02 Regulatory
Jörgen Vrenning is retiring as CFO of NeoDynamics
Read more

2020-10-21 Regulatory
NeoDynamics carries out directed new share issue of approximately SEK 90 million and convenes extraordinary general meeting
Read more

2020-10-21 Regulatory
NeoDynamics announces intention to carry out a directed share issue of approximately 24 million shares and intention to call for Extraordinary General Meeting
Read more

2020-09-25
NeoDynamics is approaching launch of new pulse biopsy system NeoNavia - reputed international gynecologists and radiologists gained positive hands-on experience
Read more

2020-08-21 Regulatory
NeoDynamics AB (publ) Half year report 2020
Read more

2020-07-06 Regulatory
NeoDynamics establishes reference centres in Germany to support the introduction of its novel pulse biopsy system NeoNavia and optimize the diagnosis of breast cancer
Read more

2020-07-06 Regulatory
NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer
Read more

2020-05-26 Regulatory
NeoDynamics AB (publ) First Quarter 2020
Read more

2020-02-05 Regulatory
NeoDynamics AB (publ) full-year report 2019
Read more

2020-02-03
A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.
Read more

2020-01-28
NeoDynamics AB (publ) receives notification of granted patent on biopsy instrument in China
Read more

2019-11-27
NeoDynamics signs manufacturing agreement for NeoNavia
Read more

2019-11-21 Regulatory
NeoDynamics AB (publ) Third quarter Jul-Sep 2019
Read more

2019-11-05
For the first time in UK, a wider audience can get first-hand experience of the NeoNavia® micropulse biopsy system for breast cancer
Read more

2019-10-29 Regulatory
NeoDynamics receives regulatory approval for new breast cancer biopsy system
Read more

2019-09-16
NeoDynamics recruits a country manager for Germany, Switzerland and Austria
Read more

2019-08-28 Regulatory
NeoDynamics has secured financing through the issue of convertibles and calls for an Extraordinary General Meeting
Read more

2019-08-28 Regulatory
NeoDynamics Half-year report 2019
Read more

2019-08-15
New date for NeoDynamics semi-annual report 2019
Read more

2019-05-22 Regulatory
NeoDynamics AB (publ) invests in biopsy instrument for more effective sampling of suspected skin cancer
Read more

2019-05-21 Regulatory
NeoDynamics AB (publ) - Quarterly report January-March 2019
Read more

2019-04-26 Regulatory
NeoDynamics AB (publ) receives advance notice from U.S. Patent Office for a granted biopsy instrument patent
Read more

2019-04-10
New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm
Read more

2019-02-21 Regulatory
Year-end report 2018 - NeoDynamics
Read more

2019-02-18
New Swedish technology for breast cancer diagnosis tested by leading experts in Germany
Read more

2018-12-07
NeoNavia commercial version fully integrated according to plan
Read more

2018-12-07
First day of trading in NeoDynamics’ shares and warrants on Spotlight Stock Market
Read more

2018-11-19 Regulatory
NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market fully subscribed
Read more

2018-11-12
NeoDynamics participates on Stora Aktiedagen and in a Live Session with Småbolagsjakten today
Read more

2018-11-06
NeoDynamics participates in investor meetings during the IPO
Read more

2018-11-06
NeoDynamics introduces NeoNavia®, a micropulse biopsy system, to a wider audience in the UK
Read more

2018-11-01
New technology from NeoDynamics approved for study in Germany
Read more

2018-10-31 Regulatory
The subscription period in NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market begins today
Read more

2018-10-30 Regulatory
NeoDynamics AB (publ) announces approval on passportation of prospectus
Read more

2018-10-29 Regulatory
NeoDynamics AB (publ) publishes prospectus and enters agreement on additional subscription commitment
Read more

2018-10-25 Regulatory
NeoDynamics AB (publ) approved for listing on Spotlight Stock Market
Read more